ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

240 hedge funds and large institutions have $4.88B invested in Intra-Cellular Therapies Inc. in 2022 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 90 increasing their positions, 64 reducing their positions, and 31 closing their positions.

Holders
240
Holders Change
+33
Holders Change %
+15.94%
% of All Funds
3.8%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.21%
New
66
Increased
90
Reduced
64
Closed
31
Calls
$33.7M
Puts
$16.4M
Net Calls
+$17.3M
Net Calls Change
-$19.4M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$249M
2
Victory Capital Management
2
Victory Capital Management
Texas
$56.9M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$477M
4
BlackRock
4
BlackRock
New York
$396M
5
Holocene Advisors
5
Holocene Advisors
New York
$44.2M

Top Sellers

1
WA
1
Wasatch Advisors
Utah
$458M
2
SC
2
Samlyn Capital
New York
$29.6M
3
TCM
3
TimesSquare Capital Management
New York
$53.7M
4
IBT
4
International Biotechnology Trust
United Kingdom
$20.9M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$37.2M 607,737 +89,260 +17%
Citadel Advisors
27
Citadel Advisors
Florida
$36.7M 599,032 -151,684 -20%
BGIM
28
Brandywine Global Investment Management
Pennsylvania
$34.8M 568,811 -6,167 -1%
NIP
29
Nicholas Investment Partners
California
$34.4M 562,373 -90,513 -14%
GKIM
30
GW&K Investment Management
Massachusetts
$33.6M 549,327 +176,007 +47%
Deutsche Bank
31
Deutsche Bank
Germany
$31.3M 512,304 -2,996 -0.6%
HRCM
32
Hood River Capital Management
Florida
$31.3M 510,830 +510,830 New
DCM
33
Driehaus Capital Management
Illinois
$29.9M 488,460 +488,460 New
SC
34
Samlyn Capital
New York
$29.6M 484,103 -625,752 -56%
Goldman Sachs
35
Goldman Sachs
New York
$29.3M 478,718 +243,475 +103%
Invesco
36
Invesco
Georgia
$29.3M 478,385 +445,945 +1,375%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$28.3M 467,397 +178,420 +62%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$27.2M 444,375 +61,756 +16%
Skandinaviska Enskilda Banken (SEB)
39
Skandinaviska Enskilda Banken (SEB)
Sweden
$24M 391,937 -4,342 -1%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$23.6M 385,508 +18,999 +5%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$22.3M 364,618 +211,031 +137%
IBT
42
International Biotechnology Trust
United Kingdom
$20.9M 50,956 -62,500 -55%
TCM
43
Tekla Capital Management
Massachusetts
$17.8M 290,936 +54,489 +23%
Prudential Financial
44
Prudential Financial
New Jersey
$17.4M 283,598 +167,433 +144%
GAI
45
General American Investors
New York
$17.3M 283,439 – –
RPAM
46
Rhenman & Partners Asset Management
Sweden
$17.1M 280,000 -110,000 -28%
LCG
47
Lisanti Capital Growth
New York
$17M 278,395 +278,395 New
PPA
48
Parametric Portfolio Associates
Washington
$16.5M 269,677 -4,903 -2%
GPSPJS
49
General Pension Society PZU Joint Stock
Poland
$16M 260,812 -21,257 -8%
UBS AM
50
UBS AM
Illinois
$15.1M 247,234 +174,038 +238%
1
2
3 4 5